Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 10:31 PM
Ignite Modification Date: 2025-12-25 @ 8:04 PM
NCT ID: NCT01601535
Term: Palpitations
Organ System: Cardiac disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE v4.0
Notes: As requested, we are reporting all toxicities of all grades, whether or not they are related to the regimen or known to be related to non-treatment causes.
Study: NCT01601535
Study Brief: Study of MLN8237 in Combination With Irinotecan and Temozolomide
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 2 1 6 View
EG001 0 0 6 View
EG002 0 0 6 View
EG003 0 0 4 View
EG004 1 1 20 View
EG005 0 0 12 View